Home » Topics » BioWorld Science, Immune

BioWorld Science, Immune
RSS

Positive phase I safety profile for Immunex's new product candidate

Feb. 14, 1997

Melatonin in immunity, aging and cancer

Feb. 12, 1997

U.S. patent issued for meningococcal B vaccine

Feb. 11, 1997

CEAPRO receives patent coverage for potential vaccine adjuvants

Feb. 7, 1997

Legionella vaccine described by U.S. researchers

Feb. 7, 1997

Clinical trial data reported for meningitis vaccine

Feb. 6, 1997

BTG describes immunosuppressive antibodies

Feb. 6, 1997

SmithKline Beecham Lyme disease vaccine update

Feb. 5, 1997

Tularik receives patent coverage for protein involved in immune response

Feb. 4, 1997

SKB acellular DTP vaccine approved in U.S.

Jan. 31, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 31, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 31, 2025.
Shionogi nabs revenue-generating ALS drugs with $2.5B Tanabe pact
BioWorld
Shionogi & Co. Ltd. will acquire global rights to U.S. FDA approved amyotrophic lateral sclerosis therapy edaravone through a $2.5 billion acquisition deal with...
Big pharma taps fast Asia innovation in search of next Keytruda
BioWorld
Speed and innovation from Asia Pacific’s (APAC) biotechnology sector had big pharma scouring the region for the next oncology heir to Keytruda (pembrolizumab),...
IMV-101 shows promise for B-cell malignancies
BioWorld Science
IMV-101 is a new CAR T-cell therapy targeting CD19 developed by Suzhou Immunofoco Biotechnology Co. Ltd. for the potential treatment of B-cell malignancies and...